171 related articles for article (PubMed ID: 33049330)
1. Microsphere antioxidant and sustained erythropoietin-R76E release functions cooperate to reduce traumatic optic neuropathy.
DeJulius CR; Bernardo-Colón A; Naguib S; Backstrom JR; Kavanaugh T; Gupta MK; Duvall CL; Rex TS
J Control Release; 2021 Jan; 329():762-773. PubMed ID: 33049330
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent treatment of optic nerve crush by exogenous systemic mutant erythropoietin.
Sullivan TA; Geisert EE; Templeton JP; Rex TS
Exp Eye Res; 2012 Mar; 96(1):36-41. PubMed ID: 22306016
[TBL] [Abstract][Full Text] [Related]
3. Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway.
Naguib S; DeJulius CR; Backstrom JR; Haider AA; Ang JM; Boal AM; Calkins DJ; Duvall CL; Rex TS
Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978804
[TBL] [Abstract][Full Text] [Related]
4. Effects of erythropoietin-dextran microparticle-based PLGA/PLA microspheres on RGCs.
Rong X; Yang S; Miao H; Guo T; Wang Z; Shi W; Mo X; Yuan W; Jin T
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6025-34. PubMed ID: 22871834
[TBL] [Abstract][Full Text] [Related]
5. Safety and angiogenic effects of systemic gene delivery of a modified erythropoietin.
de Lucas Cerrillo AM; Bond WS; Rex TS
Gene Ther; 2015 May; 22(5):365-73. PubMed ID: 25716531
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin Gene Therapy Delays Retinal Degeneration Resulting from Oxidative Stress in the Retinal Pigment Epithelium.
Biswal MR; Wang Z; Paulson RJ; Uddin RR; Tong Y; Zhu P; Li H; Lewin AS
Antioxidants (Basel); 2021 May; 10(6):. PubMed ID: 34070383
[TBL] [Abstract][Full Text] [Related]
7. Localized and sustained delivery of erythropoietin from PLGA microspheres promotes functional recovery and nerve regeneration in peripheral nerve injury.
Zhang W; Gao Y; Zhou Y; Liu J; Zhang L; Long A; Zhang L; Tang P
Biomed Res Int; 2015; 2015():478103. PubMed ID: 25821803
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing.
Bricker-Anthony C; D'Surney L; Lunn B; Hines-Beard J; Jo M; Bernardo-Colon A; Rex TS
Optom Vis Sci; 2017 Jan; 94(1):20-32. PubMed ID: 27281679
[TBL] [Abstract][Full Text] [Related]
9. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation.
Geng Y; Yuan W; Wu F; Chen J; He M; Jin T
J Control Release; 2008 Sep; 130(3):259-65. PubMed ID: 18620011
[TBL] [Abstract][Full Text] [Related]
10. Neovascularization by Sustained Delivery of G-CSF, EPO and VEGF Using Dextran/PLGA Microspheres.
Liu CD; Tu XF; Chen F
Ann Vasc Surg; 2020 Apr; 64():328-338. PubMed ID: 31634610
[TBL] [Abstract][Full Text] [Related]
11. ROS-responsive microspheres for on demand antioxidant therapy in a model of diabetic peripheral arterial disease.
Poole KM; Nelson CE; Joshi RV; Martin JR; Gupta MK; Haws SC; Kavanaugh TE; Skala MC; Duvall CL
Biomaterials; 2015 Feb; 41():166-75. PubMed ID: 25522975
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of erythropoietin-loaded composite microspheres on retinal ganglion cells in rats.
Rong X; Mo X; Ren T; Yang S; Yuan W; Dong J; Wang Y; Wang X
Eur J Pharm Sci; 2011 Jul; 43(4):334-42. PubMed ID: 21621611
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair.
Lai YF; Lin TY; Ho PK; Chen YH; Huang YC; Lu DW
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806148
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable recombinant human erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: influence of encapsulation technique and polymer composition on particle characteristics.
Pistel KF; Bittner B; Koll H; Winter G; Kissel T
J Control Release; 1999 Jun; 59(3):309-25. PubMed ID: 10332063
[TBL] [Abstract][Full Text] [Related]
15. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair.
Kang CE; Poon PC; Tator CH; Shoichet MS
Tissue Eng Part A; 2009 Mar; 15(3):595-604. PubMed ID: 18991489
[TBL] [Abstract][Full Text] [Related]
16. Sustained efficacy of erythropoietin with a hydroxyapatite carrier administered in mice.
Nagasaki K; Ikoma T; Katsuda S; Tonegawa T; Tanaka J; Nakamura T; Sato H; Ito S; Sasaki N; Agui T
J Vet Med Sci; 2009 Jun; 71(6):729-36. PubMed ID: 19578280
[TBL] [Abstract][Full Text] [Related]
17. The preparation of sustained release erythropoietin microparticle.
Yeh MK; Chen JL; Chiang CH; Chang ZY
J Microencapsul; 2007 Feb; 24(1):82-93. PubMed ID: 17438944
[TBL] [Abstract][Full Text] [Related]
18. Identification of a therapeutic dose of continuously delivered erythropoietin in the eye using an inducible promoter system.
Hines-Beard J; Desai S; Haag R; Esumi N; D'Surney L; Parker S; Richardson C; Rex TS
Curr Gene Ther; 2013 Aug; 13(4):275-81. PubMed ID: 23773177
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin-PLGA-PEG as a local treatment to promote functional recovery and neurovascular regeneration after peripheral nerve injury.
Manto KM; Govindappa PK; Martinazzi B; Han A; Hegarty JP; Koroneos Z; Talukder MAH; Elfar JC
J Nanobiotechnology; 2022 Oct; 20(1):461. PubMed ID: 36307805
[TBL] [Abstract][Full Text] [Related]
20. Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma.
Naguib S; Bernardo-Colón A; Cencer C; Gandra N; Rex TS
Neurobiol Dis; 2020 Feb; 134():104695. PubMed ID: 31778813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
